Article
Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models
15 May 2017
Abstract excerpt
Glial cell line-derived neurotrophic factor (GDNF) protein and gene therapy are currently under clinical investigation in Parkinson’s disease (PD) patients. GDNF has profound protective effects on dopamine neurons in numerous neurotoxicant PD models in rats and non-human primates.1,2 However, in another PD model generated by recombinant adeno-associated virus (rAAV) vector transduction of human alpha-synuclein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
